Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery

Postpartum Infectious Morbidity in Cesarean Section Delivery Clinical Trial

Official title: Role of Skin Cleansing and Prophylactic Antibiotic in Preventing Infectious Morbidity After Cesarean Section Delivery

Status Not yet recruiting

Clinical Trial Summary

This study aims to determine the effectiveness of skin cleansing and prophylactic antibiotics given to women undergoing a cesarean section for reducing the incidence of postpartum infectious morbidity and to assess potential maternal adverse effects and any impact on the infant.

Clinical Trial Description

n/a

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

• Communicable Diseases
• Infection
• Postpartum Infectious Morbidity in Cesarean Section Delivery

• NCT number: NCT03007706
• Study type: Observational [Patient Registry]
• Source: Minia Maternity University Hospital
• Status: Not yet recruiting
• Phase: N/A
• Start date: January 2017
• Completion date: October 2017